nodes	percent_of_prediction	percent_of_DWPC	metapath
Glipizide—CYP2C9—Tretinoin—peripheral nervous system neoplasm	0.117	0.302	CbGbCtD
Glipizide—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0731	0.189	CbGbCtD
Glipizide—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.068	0.176	CbGbCtD
Glipizide—CYP2C9—Cisplatin—peripheral nervous system neoplasm	0.0501	0.129	CbGbCtD
Glipizide—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.0312	0.0806	CbGbCtD
Glipizide—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.0286	0.0738	CbGbCtD
Glipizide—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.0195	0.0504	CbGbCtD
Glipizide—PPARG—Irinotecan—Topotecan—peripheral nervous system neoplasm	0.0116	0.728	CbGdCrCtD
Glipizide—PPARG—Teniposide—Etoposide—peripheral nervous system neoplasm	0.00436	0.272	CbGdCrCtD
Glipizide—Migraine—Epirubicin—peripheral nervous system neoplasm	0.000737	0.00123	CcSEcCtD
Glipizide—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000733	0.00123	CcSEcCtD
Glipizide—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000733	0.00123	CcSEcCtD
Glipizide—Insomnia—Vincristine—peripheral nervous system neoplasm	0.000733	0.00123	CcSEcCtD
Glipizide—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.000731	0.00122	CcSEcCtD
Glipizide—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.000727	0.00122	CcSEcCtD
Glipizide—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.000726	0.00122	CcSEcCtD
Glipizide—Malaise—Etoposide—peripheral nervous system neoplasm	0.000725	0.00122	CcSEcCtD
Glipizide—Vertigo—Etoposide—peripheral nervous system neoplasm	0.000722	0.00121	CcSEcCtD
Glipizide—Leukopenia—Etoposide—peripheral nervous system neoplasm	0.00072	0.00121	CcSEcCtD
Glipizide—Pain—Alitretinoin—peripheral nervous system neoplasm	0.000719	0.0012	CcSEcCtD
Glipizide—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.000719	0.0012	CcSEcCtD
Glipizide—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.000717	0.0012	CcSEcCtD
Glipizide—Oedema—Cisplatin—peripheral nervous system neoplasm	0.000716	0.0012	CcSEcCtD
Glipizide—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000711	0.00119	CcSEcCtD
Glipizide—Hypoglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.00071	0.00119	CcSEcCtD
Glipizide—Loss of consciousness—Etoposide—peripheral nervous system neoplasm	0.000707	0.00118	CcSEcCtD
Glipizide—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000705	0.00118	CcSEcCtD
Glipizide—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000705	0.00118	CcSEcCtD
Glipizide—Rash—Topotecan—peripheral nervous system neoplasm	0.000705	0.00118	CcSEcCtD
Glipizide—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000704	0.00118	CcSEcCtD
Glipizide—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.000704	0.00118	CcSEcCtD
Glipizide—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.000701	0.00118	CcSEcCtD
Glipizide—Headache—Topotecan—peripheral nervous system neoplasm	0.0007	0.00117	CcSEcCtD
Glipizide—Rash—Tretinoin—peripheral nervous system neoplasm	0.000699	0.00117	CcSEcCtD
Glipizide—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000699	0.00117	CcSEcCtD
Glipizide—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000699	0.00117	CcSEcCtD
Glipizide—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000699	0.00117	CcSEcCtD
Glipizide—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000699	0.00117	CcSEcCtD
Glipizide—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000696	0.00117	CcSEcCtD
Glipizide—Hyponatraemia—Doxorubicin—peripheral nervous system neoplasm	0.000695	0.00117	CcSEcCtD
Glipizide—Headache—Tretinoin—peripheral nervous system neoplasm	0.000695	0.00116	CcSEcCtD
Glipizide—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000695	0.00116	CcSEcCtD
Glipizide—Hypertension—Etoposide—peripheral nervous system neoplasm	0.000694	0.00116	CcSEcCtD
Glipizide—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000693	0.00116	CcSEcCtD
Glipizide—Constipation—Vincristine—peripheral nervous system neoplasm	0.000693	0.00116	CcSEcCtD
Glipizide—Pain—Vincristine—peripheral nervous system neoplasm	0.000693	0.00116	CcSEcCtD
Glipizide—Gastrointestinal haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000692	0.00116	CcSEcCtD
Glipizide—Diplopia—Doxorubicin—peripheral nervous system neoplasm	0.000692	0.00116	CcSEcCtD
Glipizide—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000692	0.00116	CcSEcCtD
Glipizide—Rash—Melphalan—peripheral nervous system neoplasm	0.00069	0.00116	CcSEcCtD
Glipizide—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.00069	0.00116	CcSEcCtD
Glipizide—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000687	0.00115	CcSEcCtD
Glipizide—Abdominal pain upper—Epirubicin—peripheral nervous system neoplasm	0.000683	0.00115	CcSEcCtD
Glipizide—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000683	0.00114	CcSEcCtD
Glipizide—Migraine—Doxorubicin—peripheral nervous system neoplasm	0.000682	0.00114	CcSEcCtD
Glipizide—Discomfort—Etoposide—peripheral nervous system neoplasm	0.000676	0.00113	CcSEcCtD
Glipizide—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000668	0.00112	CcSEcCtD
Glipizide—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000668	0.00112	CcSEcCtD
Glipizide—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000665	0.00111	CcSEcCtD
Glipizide—Nausea—Topotecan—peripheral nervous system neoplasm	0.000664	0.00111	CcSEcCtD
Glipizide—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000662	0.00111	CcSEcCtD
Glipizide—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000662	0.00111	CcSEcCtD
Glipizide—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000659	0.0011	CcSEcCtD
Glipizide—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000659	0.0011	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000653	0.00109	CcSEcCtD
Glipizide—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.00065	0.00109	CcSEcCtD
Glipizide—Nausea—Melphalan—peripheral nervous system neoplasm	0.00065	0.00109	CcSEcCtD
Glipizide—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000643	0.00108	CcSEcCtD
Glipizide—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.000642	0.00108	CcSEcCtD
Glipizide—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.00064	0.00107	CcSEcCtD
Glipizide—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000639	0.00107	CcSEcCtD
Glipizide—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000634	0.00106	CcSEcCtD
Glipizide—Abdominal pain upper—Doxorubicin—peripheral nervous system neoplasm	0.000632	0.00106	CcSEcCtD
Glipizide—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000625	0.00105	CcSEcCtD
Glipizide—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000623	0.00104	CcSEcCtD
Glipizide—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.00062	0.00104	CcSEcCtD
Glipizide—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000619	0.00104	CcSEcCtD
Glipizide—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000618	0.00104	CcSEcCtD
Glipizide—Pancytopenia—Epirubicin—peripheral nervous system neoplasm	0.000614	0.00103	CcSEcCtD
Glipizide—Pain—Cisplatin—peripheral nervous system neoplasm	0.000612	0.00103	CcSEcCtD
Glipizide—Dysuria—Epirubicin—peripheral nervous system neoplasm	0.000605	0.00101	CcSEcCtD
Glipizide—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000603	0.00101	CcSEcCtD
Glipizide—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000597	0.001	CcSEcCtD
Glipizide—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000595	0.000997	CcSEcCtD
Glipizide—Photosensitivity reaction—Epirubicin—peripheral nervous system neoplasm	0.00059	0.00099	CcSEcCtD
Glipizide—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.00059	0.000989	CcSEcCtD
Glipizide—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000589	0.000988	CcSEcCtD
Glipizide—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000585	0.000981	CcSEcCtD
Glipizide—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000583	0.000978	CcSEcCtD
Glipizide—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000581	0.000974	CcSEcCtD
Glipizide—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.000577	0.000967	CcSEcCtD
Glipizide—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000576	0.000966	CcSEcCtD
Glipizide—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000575	0.000964	CcSEcCtD
Glipizide—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000572	0.000958	CcSEcCtD
Glipizide—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.00057	0.000956	CcSEcCtD
Glipizide—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000568	0.000953	CcSEcCtD
Glipizide—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000566	0.000949	CcSEcCtD
Glipizide—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.000562	0.000942	CcSEcCtD
Glipizide—Pain—Etoposide—peripheral nervous system neoplasm	0.000561	0.00094	CcSEcCtD
Glipizide—Constipation—Etoposide—peripheral nervous system neoplasm	0.000561	0.00094	CcSEcCtD
Glipizide—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	0.000561	0.00094	CcSEcCtD
Glipizide—Dysuria—Doxorubicin—peripheral nervous system neoplasm	0.00056	0.000938	CcSEcCtD
Glipizide—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000556	0.000932	CcSEcCtD
Glipizide—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000554	0.000929	CcSEcCtD
Glipizide—Sweating—Epirubicin—peripheral nervous system neoplasm	0.000553	0.000927	CcSEcCtD
Glipizide—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	0.000546	0.000916	CcSEcCtD
Glipizide—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	0.000545	0.000914	CcSEcCtD
Glipizide—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000541	0.000906	CcSEcCtD
Glipizide—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000539	0.000903	CcSEcCtD
Glipizide—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.000538	0.000902	CcSEcCtD
Glipizide—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000537	0.000899	CcSEcCtD
Glipizide—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000536	0.000898	CcSEcCtD
Glipizide—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000534	0.000896	CcSEcCtD
Glipizide—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.000534	0.000894	CcSEcCtD
Glipizide—Rash—Alitretinoin—peripheral nervous system neoplasm	0.00053	0.000888	CcSEcCtD
Glipizide—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.00053	0.000888	CcSEcCtD
Glipizide—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000528	0.000884	CcSEcCtD
Glipizide—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000527	0.000883	CcSEcCtD
Glipizide—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000521	0.000874	CcSEcCtD
Glipizide—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.00052	0.000872	CcSEcCtD
Glipizide—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.000519	0.00087	CcSEcCtD
Glipizide—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000519	0.000869	CcSEcCtD
Glipizide—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	0.000519	0.000869	CcSEcCtD
Glipizide—Hepatitis—Epirubicin—peripheral nervous system neoplasm	0.000518	0.000868	CcSEcCtD
Glipizide—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.000515	0.000863	CcSEcCtD
Glipizide—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000515	0.000863	CcSEcCtD
Glipizide—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000514	0.000861	CcSEcCtD
Glipizide—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000514	0.000861	CcSEcCtD
Glipizide—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.000512	0.000857	CcSEcCtD
Glipizide—Rash—Vincristine—peripheral nervous system neoplasm	0.000511	0.000856	CcSEcCtD
Glipizide—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.00051	0.000855	CcSEcCtD
Glipizide—Headache—Vincristine—peripheral nervous system neoplasm	0.000507	0.000851	CcSEcCtD
Glipizide—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	0.000505	0.000846	CcSEcCtD
Glipizide—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000499	0.000837	CcSEcCtD
Glipizide—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.000499	0.000836	CcSEcCtD
Glipizide—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.000498	0.000835	CcSEcCtD
Glipizide—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.00049	0.000821	CcSEcCtD
Glipizide—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.000484	0.000811	CcSEcCtD
Glipizide—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000483	0.00081	CcSEcCtD
Glipizide—Nausea—Vincristine—peripheral nervous system neoplasm	0.000481	0.000806	CcSEcCtD
Glipizide—Flushing—Epirubicin—peripheral nervous system neoplasm	0.00048	0.000805	CcSEcCtD
Glipizide—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.00048	0.000805	CcSEcCtD
Glipizide—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	0.000479	0.000803	CcSEcCtD
Glipizide—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000477	0.000799	CcSEcCtD
Glipizide—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000475	0.000797	CcSEcCtD
Glipizide—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000471	0.000789	CcSEcCtD
Glipizide—Chills—Epirubicin—peripheral nervous system neoplasm	0.000465	0.000779	CcSEcCtD
Glipizide—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000464	0.000778	CcSEcCtD
Glipizide—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.000462	0.000775	CcSEcCtD
Glipizide—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.000462	0.000774	CcSEcCtD
Glipizide—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000455	0.000763	CcSEcCtD
Glipizide—Rash—Cisplatin—peripheral nervous system neoplasm	0.000452	0.000757	CcSEcCtD
Glipizide—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000451	0.000756	CcSEcCtD
Glipizide—Erythema—Epirubicin—peripheral nervous system neoplasm	0.000451	0.000755	CcSEcCtD
Glipizide—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000449	0.000752	CcSEcCtD
Glipizide—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.000448	0.00075	CcSEcCtD
Glipizide—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.000445	0.000745	CcSEcCtD
Glipizide—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.000444	0.000744	CcSEcCtD
Glipizide—Tension—Epirubicin—peripheral nervous system neoplasm	0.000442	0.000741	CcSEcCtD
Glipizide—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000438	0.000734	CcSEcCtD
Glipizide—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000434	0.000727	CcSEcCtD
Glipizide—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000433	0.000726	CcSEcCtD
Glipizide—Chills—Doxorubicin—peripheral nervous system neoplasm	0.00043	0.00072	CcSEcCtD
Glipizide—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.000428	0.000717	CcSEcCtD
Glipizide—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000425	0.000713	CcSEcCtD
Glipizide—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000425	0.000712	CcSEcCtD
Glipizide—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000418	0.000701	CcSEcCtD
Glipizide—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000417	0.000699	CcSEcCtD
Glipizide—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.000417	0.000699	CcSEcCtD
Glipizide—Rash—Etoposide—peripheral nervous system neoplasm	0.000414	0.000693	CcSEcCtD
Glipizide—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000413	0.000693	CcSEcCtD
Glipizide—Headache—Etoposide—peripheral nervous system neoplasm	0.000411	0.000689	CcSEcCtD
Glipizide—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.000411	0.000689	CcSEcCtD
Glipizide—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000409	0.000686	CcSEcCtD
Glipizide—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000406	0.000681	CcSEcCtD
Glipizide—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.000405	0.000679	CcSEcCtD
Glipizide—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000405	0.000679	CcSEcCtD
Glipizide—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000404	0.000677	CcSEcCtD
Glipizide—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.000403	0.000676	CcSEcCtD
Glipizide—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000401	0.000672	CcSEcCtD
Glipizide—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000396	0.000664	CcSEcCtD
Glipizide—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.000393	0.000659	CcSEcCtD
Glipizide—Nausea—Etoposide—peripheral nervous system neoplasm	0.00039	0.000653	CcSEcCtD
Glipizide—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000389	0.000652	CcSEcCtD
Glipizide—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000387	0.000648	CcSEcCtD
Glipizide—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000384	0.000643	CcSEcCtD
Glipizide—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000384	0.000643	CcSEcCtD
Glipizide—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000382	0.000641	CcSEcCtD
Glipizide—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000379	0.000635	CcSEcCtD
Glipizide—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000376	0.00063	CcSEcCtD
Glipizide—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000375	0.000628	CcSEcCtD
Glipizide—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000374	0.000627	CcSEcCtD
Glipizide—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.000373	0.000626	CcSEcCtD
Glipizide—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000371	0.000622	CcSEcCtD
Glipizide—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000368	0.000616	CcSEcCtD
Glipizide—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000367	0.000614	CcSEcCtD
Glipizide—Shock—Epirubicin—peripheral nervous system neoplasm	0.000362	0.000607	CcSEcCtD
Glipizide—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.00036	0.000604	CcSEcCtD
Glipizide—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.00036	0.000603	CcSEcCtD
Glipizide—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000356	0.000596	CcSEcCtD
Glipizide—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000355	0.000595	CcSEcCtD
Glipizide—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000355	0.000595	CcSEcCtD
Glipizide—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.000354	0.000593	CcSEcCtD
Glipizide—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000351	0.000588	CcSEcCtD
Glipizide—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000351	0.000588	CcSEcCtD
Glipizide—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000343	0.000575	CcSEcCtD
Glipizide—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.00034	0.00057	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000335	0.000562	CcSEcCtD
Glipizide—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000335	0.000561	CcSEcCtD
Glipizide—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000333	0.000559	CcSEcCtD
Glipizide—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000333	0.000558	CcSEcCtD
Glipizide—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.00033	0.000554	CcSEcCtD
Glipizide—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000329	0.000551	CcSEcCtD
Glipizide—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000328	0.00055	CcSEcCtD
Glipizide—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000327	0.000548	CcSEcCtD
Glipizide—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000324	0.000544	CcSEcCtD
Glipizide—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000324	0.000543	CcSEcCtD
Glipizide—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.00032	0.000536	CcSEcCtD
Glipizide—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000318	0.000532	CcSEcCtD
Glipizide—Pain—Epirubicin—peripheral nervous system neoplasm	0.000315	0.000527	CcSEcCtD
Glipizide—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000315	0.000527	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.00031	0.00052	CcSEcCtD
Glipizide—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000308	0.000516	CcSEcCtD
Glipizide—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000306	0.000512	CcSEcCtD
Glipizide—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000303	0.000509	CcSEcCtD
Glipizide—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000303	0.000508	CcSEcCtD
Glipizide—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000303	0.000507	CcSEcCtD
Glipizide—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000301	0.000504	CcSEcCtD
Glipizide—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.0003	0.000502	CcSEcCtD
Glipizide—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000296	0.000496	CcSEcCtD
Glipizide—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000294	0.000492	CcSEcCtD
Glipizide—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000292	0.00049	CcSEcCtD
Glipizide—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000291	0.000488	CcSEcCtD
Glipizide—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000291	0.000488	CcSEcCtD
Glipizide—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000291	0.000487	CcSEcCtD
Glipizide—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.00028	0.00047	CcSEcCtD
Glipizide—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000278	0.000466	CcSEcCtD
Glipizide—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000271	0.000454	CcSEcCtD
Glipizide—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.00027	0.000453	CcSEcCtD
Glipizide—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000269	0.000451	CcSEcCtD
Glipizide—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000264	0.000442	CcSEcCtD
Glipizide—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.00026	0.000436	CcSEcCtD
Glipizide—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000252	0.000422	CcSEcCtD
Glipizide—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000251	0.00042	CcSEcCtD
Glipizide—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000244	0.000409	CcSEcCtD
Glipizide—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000243	0.000408	CcSEcCtD
Glipizide—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000241	0.000404	CcSEcCtD
Glipizide—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000234	0.000392	CcSEcCtD
Glipizide—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000233	0.00039	CcSEcCtD
Glipizide—Rash—Epirubicin—peripheral nervous system neoplasm	0.000232	0.000389	CcSEcCtD
Glipizide—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000232	0.000388	CcSEcCtD
Glipizide—Headache—Epirubicin—peripheral nervous system neoplasm	0.00023	0.000386	CcSEcCtD
Glipizide—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000225	0.000377	CcSEcCtD
Glipizide—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000218	0.000366	CcSEcCtD
Glipizide—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000216	0.000363	CcSEcCtD
Glipizide—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000215	0.00036	CcSEcCtD
Glipizide—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000214	0.000359	CcSEcCtD
Glipizide—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000213	0.000357	CcSEcCtD
Glipizide—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000202	0.000339	CcSEcCtD
Glipizide—Chlorpropamide—ABCB1—peripheral nervous system neoplasm	3.77e-05	0.597	CrCbGaD
Glipizide—Glyburide—ABCB1—peripheral nervous system neoplasm	2.55e-05	0.403	CrCbGaD
